Major depressive disorder represents one of the most significant global health challenges of the 21st century, affecting millions of people worldwide and creating substantial economic and social burdens. While conventional antidepressant therapies have provided relief for many individuals, their limitations including delayed onset of action, significant side effects, and treatment resistance in a substantial portion of patients have prompted researchers and healthcare providers to explore alternative therapeutic approaches (Kasneci et al.). African traditional medicine, with its rich heritage of plant-based remedies developed over millennia, offers a valuable resource for developing novel antidepressant treatments that may address some of these limitations. This paper examines the integration of large language models with African natural products for depression support, combining traditional knowledge with modern artificial intelligence technology to create accessible, evidence-based mental health support systems. The research presented here encompasses a comprehensive analysis of African medicinal plants with documented antidepressant properties, their pharmacological mechanisms, and the development of an AI-powered support system that leverages DeepSeek's advanced language model capabilities. The system provides evidence-based information about African herbal medicines, their clinical applications, safety considerations, and therapeutic protocols while maintaining scientific rigor and appropriate safety standards. Our findings demonstrate the potential for large language models to serve as bridges between traditional knowledge and modern healthcare, offering personalized, culturally appropriate depression support that honors both traditional wisdom and contemporary medical understanding.

Welcome to State of Mind, a section from Slate and Arizona State University dedicated to exploring mental health. I learned how to recognize strokes from TV. I must have seen the PSA urging me to "Act FAST" hundreds of times, slotted between episodes of Rugrats and Hey Arnold!, and I still recall the signs easily: facial droop, arm weakness, speech problems, timely response. Those PSAs have surely saved lives. According to the National Institutes of Health, 795,000 people have strokes each year in the U.S.; 137,000 of them die.

An international team of scientists, including a Western University researcher, have developed an artificial intelligence (AI) tool that facilitates more personalized treatments for depression and improves patient outcomes. "Our clinical trial shows that this new method of treatment selection improves the effectiveness of currently available treatments, with a small and affordable increase in overall treatment costs, since it fast-tracks more patients to intensive treatments when they need them," said Shehzad Ali, professor of public health economics at the Schulich School of Medicine & Dentistry. Ali, a Canada Research Chair in Public Health Economics, was the lead health economist and statistician on the study, which was led by the University of Sheffield in the U.K. Current practice for treating depression often involves a stepped care approach. Patients are first offered a low-intensity treatment, such as group therapy, with those who remain unwell later being moved to more intensive, lengthy treatment. The researchers behind the new tool have shown that implementing AI helps patients receive more tailored care to treat their depression much quicker.

A US research team has developed a computer that can accurately predict whether an antidepressant will work, based on patients' brain activity. The multi-site trial initiated by UT Southwestern in 2011 to better understand mood disorders -- involving Stanford, Harvard and other institutions -- demonstrates that artificial intelligence (AI) may soon help doctors objectively diagnose and prescribe depression treatments. The researchers predict that tools such as AI, brain imaging and blood tests will revolutionise the field of psychiatry in the coming years. "These studies have been a bigger success than anyone on our team could have imagined," UT Southwestern psychiatrist Dr Madhukar Trivedi said. "We provided abundant data to show we can move past the guessing game of choosing depression treatments and alter the mindset of how the disease should be diagnosed and treated."